标题
Priorities in Parkinson's disease research
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 10, Issue 5, Pages 377-393
出版商
Springer Nature
发表日期
2011-04-30
DOI
10.1038/nrd3430
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
- (2011) J. Dusonchet et al. JOURNAL OF NEUROSCIENCE
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Pathological gambling in Parkinson disease is reduced by amantadine
- (2010) Astrid Thomas et al. ANNALS OF NEUROLOGY
- Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
- (2010) Sarah C. Lidstone et al. ARCHIVES OF GENERAL PSYCHIATRY
- When Does Parkinson Disease Start?
- (2010) Rodolfo Savica et al. ARCHIVES OF NEUROLOGY
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
- (2010) P. A. Kempster et al. BRAIN
- Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature
- (2010) Patrice Péran et al. BRAIN
- In vivo visualization of -synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
- (2010) A. Kikuchi et al. BRAIN
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- Current therapeutic targets for the treatment of Alzheimer’s disease
- (2010) Joshua D Grill et al. Expert Review of Neurotherapeutics
- Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2010) Paolo Barone et al. LANCET NEUROLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
- (2010) Juliana Bronzova et al. MOVEMENT DISORDERS
- Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
- (2010) Carlo Colosimo et al. MOVEMENT DISORDERS
- Thalamic single-unit and local field potential activity in Tourette syndrome
- (2010) Sara Marceglia et al. MOVEMENT DISORDERS
- Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
- (2010) Karla Eggert et al. MOVEMENT DISORDERS
- Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly
- (2010) Daniela Berg et al. MOVEMENT DISORDERS
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Molecular and clinical prodrome of Parkinson disease: implications for treatment
- (2010) Anthony H. V. Schapira et al. Nature Reviews Neurology
- Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
- (2010) Karin D. van Dijk et al. NEUROBIOLOGY OF DISEASE
- Rasagiline, Parkinson neuroprotection, and delayed-start trials: Still no satisfaction?
- (2010) J. E. Ahlskog et al. NEUROLOGY
- Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
- (2010) M. Politis et al. NEUROLOGY
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
- (2010) D. Aarsland et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
- (2010) T. A. Zesiewicz et al. NEUROLOGY
- SNCAvariants are associated with increased risk for multiple system atrophy
- (2009) Sonja W. Scholz et al. ANNALS OF NEUROLOGY
- Unilateral pedunculopontine stimulation improves falls in Parkinson's disease
- (2009) E. Moro et al. BRAIN
- Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease
- (2009) M. U. Ferraye et al. BRAIN
- Caffeine and Progression of Parkinson Disease
- (2009) David K. Simon et al. CLINICAL NEUROPHARMACOLOGY
- Adenosine and Sleep
- (2009) Theresa Bjorness et al. Current Neuropharmacology
- Multiple system atrophy: an update
- (2009) Nadia Stefanova et al. LANCET NEUROLOGY
- Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
- (2009) Valerie Voon et al. LANCET NEUROLOGY
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Neuropsychiatric symptoms in Parkinson's disease
- (2009) Dag Aarsland et al. MOVEMENT DISORDERS
- Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C](R)-PK11195 PET (MEMSA-trial)
- (2009) Richard Dodel et al. MOVEMENT DISORDERS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- "Disease-modification" trials in Parkinson disease: Target populations, endpoints and study design
- (2009) O. Rascol NEUROLOGY
- High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
- (2009) D. E. Vaillancourt et al. NEUROLOGY
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
- (2008) Gilbert Bensimon et al. BRAIN
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease
- (2008) CLINICAL NEUROPHARMACOLOGY
- Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases
- (2008) Silvia A. Mandel et al. CNS Neuroscience & Therapeutics
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study
- (2008) Mary M Hulihan et al. LANCET NEUROLOGY
- Transcranial sonography in movement disorders
- (2008) Daniela Berg et al. LANCET NEUROLOGY
- Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study
- (2008) David Devos et al. MOVEMENT DISORDERS
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism
- (2008) John G. Nutt et al. MOVEMENT DISORDERS
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
- (2008) Laura Marsh et al. MOVEMENT DISORDERS
- A controlled trial of antidepressants in patients with Parkinson disease and depression
- (2008) M. Menza et al. NEUROLOGY
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- Progression of dopaminergic dysfunction in a LRRK2 kindred: A multitracer PET study
- (2008) R. Nandhagopal et al. NEUROLOGY
- Second consensus statement on the diagnosis of multiple system atrophy
- (2008) S. Gilman et al. NEUROLOGY
- Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
- (2008) W. R. W. Martin et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now